These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
23. Enalapril in the treatment of renovascular hypertension. Knecht A; Grossman E; Rosenthal T Clin Exp Hypertens A; 1985; 7(10):1377-93. PubMed ID: 3000654 [TBL] [Abstract][Full Text] [Related]
24. Advances in the medical management of renovascular hypertension. Vidt DG Urol Clin North Am; 1984 Aug; 11(3):417-24. PubMed ID: 6087531 [TBL] [Abstract][Full Text] [Related]
25. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
26. [Therapy of diabetic nephropathy]. Barna I Orv Hetil; 2003 Jan; 144(4):165-72. PubMed ID: 12621814 [TBL] [Abstract][Full Text] [Related]
29. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension]. Klaus D Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960 [TBL] [Abstract][Full Text] [Related]
30. [Nuclear medicine in the study of renovascular hypertension]. Rodríguez Fernández A; López Ruiz JM; Acosta Gómez MJ; Martínez del Valle MD; Llamas Elvira JM Rev Esp Med Nucl; 1999 Aug; 18(4):302-9. PubMed ID: 10610229 [No Abstract] [Full Text] [Related]
31. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
32. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors. Rollins G Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699 [No Abstract] [Full Text] [Related]
33. Vasodilators, antihypertensive therapy and the kidney. Hollenberg NK Am J Cardiol; 1987 Dec; 60(17):57I-60I. PubMed ID: 3687806 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury. Jackson B; Johnston CI J Hum Hypertens; 1989 Jun; 3 Suppl 1():107-15. PubMed ID: 2674436 [TBL] [Abstract][Full Text] [Related]
36. Comparison of renin-angiotensin to calcium channel blockade in renal disease. Tikkanen I; Johnston CI Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414 [TBL] [Abstract][Full Text] [Related]
37. Current trends in the treatment of hypertension in renal disease. Brown EA Przegl Lek; 1998; 55 Suppl 1():61. PubMed ID: 9857700 [No Abstract] [Full Text] [Related]
38. [How I treat.... hypertension with non-diabetic renal insufficiency]. Krzesinski JM Rev Med Liege; 1994 Jul; 49(7):373-4. PubMed ID: 8052760 [No Abstract] [Full Text] [Related]
39. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders. Götz R; Heidbreder E; Heidland A Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721 [TBL] [Abstract][Full Text] [Related]